跳至主要内容
临床试验/IRCT20210528051416N1
IRCT20210528051416N1招募中3 期

Evaluating the effect of melatonin on positive and negative symptoms of schizophrenic patients admitted to psychiatry ward of Golestan hospital in 2021-2022

Ahvaz University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients who have admitted in psychiatry ward of Golestan hospital
  • Age 18-65 years
  • Schizophrenic patient according to DSM-5
  • Satisfaction of patients' guardianship
  • Schizophrenic patients who have treated with risperidone

排除标准

  • Treatment with any psych medications except for risperidone
  • Comorbidity of other psychopathologies
  • Abuse of any substance, drug, or alcohol
  • Drug reaction to melatonin or placebo
  • Past history of treatment with clozapine or melatonin
  • Pregnancy, mental retardation or any other neurologic and neurocognitive disorders, sleep apnea
  • Proven depression according to Calgary scale
  • Treatment with ECT in the current episode

研究者

相似试验